Accsys Technologies annual cash and equivalents
2022
2023
2024
2025
2026
Accsys Technologies Cash & Equivalents Growth & History (AXS)
Accsys Technologies's cash and equivalents was €17.4M for fiscal 2026.
View full Accsys Technologies company overviewAccsys Technologies annual cash and equivalents history
| Fiscal year | Period ended | Cash and equivalents | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | €17.4M | −€21,000 | −0.12% |
| 2025 | 2025-03-31 | €17.4M | −€10.0M | −36.48% |
| 2024 | 2024-03-31 | €27.4M | €834,000 | +3.14% |
| 2023 | 2023-03-31 | €26.6M | −€15.5M | −36.76% |
| 2022 | 2022-03-31 | €42.1M | — | — |
Accsys Technologies quarterly cash and equivalents
Q4.25
Q2.26
Q4.26
| Fiscal quarter | Period ended | Cash and equivalents | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-03-31 | €17.4M | −€21,000 | −0.12% |
| Q2 2026 | 2025-09-30 | €17.2M | — | — |
| Q4 2025 | 2025-03-31 | €17.4M | — | — |
Accsys Technologies cash and equivalents trends
Between the periods ended 2022-03-31 and 2026-03-31, Accsys Technologies's cash and equivalents decreased from €42.1M to €17.4M, a change of −€24.7M. The latest reported quarter, Q4 2026, shows €17.4M.
About the metric
What cash and equivalents mean
Cash and cash equivalents, often described as cash on hand, are highly liquid resources available for near-term obligations, investment, acquisitions, debt repayment, dividends, or share repurchases. This measure does not include short-term investments reported separately.
Calculation and source
Reported cash and equivalents
TickerStat standardizes cash and cash equivalents reported on the balance sheet. Restricted cash is included only when the company reports it within the selected consolidated cash concept. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Accsys Technologies source filings ↗Community posts
Accsys forecasts adjusted EBITDA below market expectations
Accsys ($AXS-LSE) expects fiscal 2027 adjusted EBITDA of €21–23 million, below its company-compiled analyst consensus of €28.8 million. Revenue in the first five months fell 6% to €56.9 million, while group sales volumes declined 11% to 22, ...
